These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32263992)

  • 1. Blending two bioengineered spider silks to develop cancer targeting spheres.
    Florczak A; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
    J Mater Chem B; 2017 Apr; 5(16):3000-3011. PubMed ID: 32263992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.
    Jastrzebska K; Florczak A; Kucharczyk K; Lin Y; Wang Q; Mackiewicz A; Kaplan DL; Dams-Kozlowska H
    Nanomedicine (Lond); 2018 Feb; 13(4):439-454. PubMed ID: 29338625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
    Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
    Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
    Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
    Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
    PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2019; 14():6855-6865. PubMed ID: 32021156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioengineering the spider silk sequence to modify its affinity for drugs.
    Kucharczyk K; Weiss M; Jastrzebska K; Luczak M; Ptak A; Kozak M; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2018; 13():4247-4261. PubMed ID: 30050299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo study of the immune response to bioengineered spider silk spheres.
    Deptuch T; Penderecka K; Kaczmarek M; Molenda S; Dams-Kozlowska H
    Sci Rep; 2022 Aug; 12(1):13480. PubMed ID: 35931709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells.
    Kucharczyk K; Florczak A; Deptuch T; Penderecka K; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
    J Nanobiotechnology; 2020 Mar; 18(1):56. PubMed ID: 32228620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The method of purifying bioengineered spider silk determines the silk sphere properties.
    Jastrzebska K; Felcyn E; Kozak M; Szybowicz M; Buchwald T; Pietralik Z; Jesionowski T; Mackiewicz A; Dams-Kozlowska H
    Sci Rep; 2016 Jun; 6():28106. PubMed ID: 27312998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
    Kucharczyk K; Florczak A; Kaminska A; Guzniczak N; Sikorska A; Deptuch T; Dams-Kozlowska H
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132016. PubMed ID: 38697442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silk as an innovative biomaterial for cancer therapy.
    Jastrzebska K; Kucharczyk K; Florczak A; Dondajewska E; Mackiewicz A; Dams-Kozlowska H
    Rep Pract Oncol Radiother; 2015; 20(2):87-98. PubMed ID: 25859397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.
    Florczak A; Jastrzebska K; Bialas W; Mackiewicz A; Dams-Kozlowska H
    J Biomed Mater Res A; 2018 Dec; 106(12):3211-3221. PubMed ID: 30242958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.
    Florczak A; Deptuch T; Lewandowska A; Penderecka K; Kramer E; Marszalek A; Mackiewicz A; Dams-Kozlowska H
    J Nanobiotechnology; 2020 Dec; 18(1):177. PubMed ID: 33261651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silk Materials Functionalized via Genetic Engineering for Biomedical Applications.
    Deptuch T; Dams-Kozlowska H
    Materials (Basel); 2017 Dec; 10(12):. PubMed ID: 29231863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS1-type bioengineered spider silk nanoparticles do not exhibit toxicity in an
    Deptuch T; Florczak A; Lewandowska A; Leporowska E; Penderecka K; Marszalek A; Mackiewicz A; Dams-Kozlowska H
    Nanomedicine (Lond); 2021 Aug; 16(18):1553-1565. PubMed ID: 34165326
    [No Abstract]   [Full Text] [Related]  

  • 18. Endotoxin reduction from biotech silk material inhibits the production of anti-silk antibodies in mice.
    Deptuch T; Kucharczyk K; Florczak A; Dams-Kozlowska H
    J Biomed Mater Res A; 2024 Mar; 112(3):463-472. PubMed ID: 37941467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailor-made spider-eggcase-silk spheres for efficient lysosomal drug delivery.
    Chen J; Hu J; Zuo P; Su X; Liu Z; Yang M
    RSC Adv; 2018 Feb; 8(17):9394-9401. PubMed ID: 35541844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silk-Based Antimicrobial Polymers as a New Platform to Design Drug-Free Materials to Impede Microbial Infections.
    Franco AR; Palma Kimmerling E; Silva C; Rodrigues FJ; Leonor IB; Reis RL; Kaplan DL
    Macromol Biosci; 2018 Dec; 18(12):e1800262. PubMed ID: 30408337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.